DE69819694D1 - Subkutan oder intradermal injizierbares implantat in der plastischen oder wiederherstellenden chirurgie - Google Patents

Subkutan oder intradermal injizierbares implantat in der plastischen oder wiederherstellenden chirurgie

Info

Publication number
DE69819694D1
DE69819694D1 DE69819694T DE69819694T DE69819694D1 DE 69819694 D1 DE69819694 D1 DE 69819694D1 DE 69819694 T DE69819694 T DE 69819694T DE 69819694 T DE69819694 T DE 69819694T DE 69819694 D1 DE69819694 D1 DE 69819694D1
Authority
DE
Germany
Prior art keywords
plastic
subcutaneally
filling
injectable implant
invention concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819694T
Other languages
English (en)
Other versions
DE69819694T2 (de
Inventor
Jerome Asius
Hatem Fessi
Franck Gouchet
Benedicte Laglenne
Elisabeth Laugier-Laglenne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69819694(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharmaceuticals Holdings Inc filed Critical Aventis Pharmaceuticals Holdings Inc
Publication of DE69819694D1 publication Critical patent/DE69819694D1/de
Application granted granted Critical
Publication of DE69819694T2 publication Critical patent/DE69819694T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/025Explicitly spheroidal or spherical shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85Polyesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059Cosmetic or alloplastic implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69819694T 1997-06-13 1998-06-12 Subkutan oder intradermal injizierbares implantat in der plastischen oder wiederherstellenden chirurgie Expired - Lifetime DE69819694T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9707334A FR2764514B1 (fr) 1997-06-13 1997-06-13 Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
FR9707334 1997-06-13
PCT/FR1998/001241 WO1998056431A1 (fr) 1997-06-13 1998-06-12 Implant injectable par voie sous-cutanee ou intradermique

Publications (2)

Publication Number Publication Date
DE69819694D1 true DE69819694D1 (de) 2003-12-18
DE69819694T2 DE69819694T2 (de) 2004-09-30

Family

ID=9507929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819694T Expired - Lifetime DE69819694T2 (de) 1997-06-13 1998-06-12 Subkutan oder intradermal injizierbares implantat in der plastischen oder wiederherstellenden chirurgie

Country Status (21)

Country Link
US (4) US6716251B1 (de)
EP (1) EP0969883B1 (de)
JP (1) JP2000516839A (de)
KR (1) KR100543560B1 (de)
AT (1) ATE253947T1 (de)
AU (1) AU744366B2 (de)
BR (1) BR9804962A (de)
CA (1) CA2263361C (de)
DE (1) DE69819694T2 (de)
DK (1) DK0969883T3 (de)
ES (1) ES2210776T3 (de)
FR (1) FR2764514B1 (de)
HK (1) HK1025268A1 (de)
HU (1) HU228462B1 (de)
IL (1) IL128210A (de)
PL (1) PL331703A1 (de)
PT (1) PT969883E (de)
RO (1) RO118261B1 (de)
RU (1) RU2214283C2 (de)
TR (1) TR199900297T1 (de)
WO (1) WO1998056431A1 (de)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
FR2778847A1 (fr) * 1998-05-20 1999-11-26 Jean Pierre Perraud Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur
JP2003509128A (ja) * 1999-09-14 2003-03-11 テファ, インコーポレイテッド 軟部組織の修復、増強および粘性補充のためのポリヒドロキシアルカノエート組成物
US6423332B1 (en) 2000-05-26 2002-07-23 Ethicon, Inc. Method and composition for deforming soft tissues
DE10026620A1 (de) * 2000-05-29 2002-03-07 Gerhard Quelle Poröse Implantate und Partikel
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
JP4510384B2 (ja) * 2001-05-23 2010-07-21 田辺三菱製薬株式会社 骨折治癒促進用組成物
JP4510383B2 (ja) * 2001-05-23 2010-07-21 田辺三菱製薬株式会社 軟骨疾患修復治療用組成物
ES2385030T3 (es) * 2001-06-29 2012-07-17 Medgraft Microtech, Inc. Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
US7744651B2 (en) * 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
CN100394989C (zh) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
US7965719B2 (en) * 2002-12-11 2011-06-21 Broadcom Corporation Media exchange network supporting multiple broadband network and service provider infrastructures
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
EP1454630B1 (de) * 2003-03-04 2010-10-20 The Technology Development Company Ltd. Injizierbare Insulinzubereitung mit Langzeitwirkung und Verfahren zur dessen Herstellung und Verwendung
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US7754233B2 (en) * 2004-09-03 2010-07-13 Ethicon, Inc. Method of preventing post-operative surgical adhesion
US8440215B2 (en) 2004-09-03 2013-05-14 Ethicon, Inc. Absorbable polymer formulations
US20060058891A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Transformable tissue bulking device
BRPI0515337A (pt) * 2004-09-16 2008-07-22 Juva Medical Inc dispositivo de aumento de tecido
US7244270B2 (en) * 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
US7641688B2 (en) * 2004-09-16 2010-01-05 Evera Medical, Inc. Tissue augmentation device
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco
US7767656B2 (en) * 2005-04-25 2010-08-03 Molly S Shoichet Blends of temperature sensitive and anionic polymers for drug delivery
US9205047B2 (en) * 2005-04-25 2015-12-08 The Governing Council Of The University Of Toronto Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
US20100210732A1 (en) * 2005-11-02 2010-08-19 Najib Babul Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
WO2007087452A2 (en) * 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Abuse resistant and extended release formulations and method of use thereof
US8329744B2 (en) * 2005-11-02 2012-12-11 Relmada Therapeutics, Inc. Methods of preventing the serotonin syndrome and compositions for use thereof
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
FR2897775B1 (fr) * 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
US8580307B2 (en) 2006-06-22 2013-11-12 Ethicon, Inc. High glass transition temperature absorbable microspheres
US9119902B2 (en) 2006-06-22 2015-09-01 Ethicon, Inc. Semi-crystalline absorbable microspheres
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
AU2007275034A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophilic abuse deterrent delivery system
US20080107744A1 (en) * 2006-11-06 2008-05-08 Jack Fa-De Chu Injectable hollow tissue filler
WO2008066382A1 (en) * 2006-11-29 2008-06-05 Cam Aesthetics B.V. I.O. Carboxymethyl cellulose-stabilised tissue filler and its preparation and use
KR100759091B1 (ko) * 2006-12-13 2007-09-17 조강선 피부 충전제 조성물
US7776840B2 (en) 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
WO2008147867A2 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
AU2008256864A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Coated hyaluronic acid particles
CN101842084B (zh) 2007-07-26 2014-11-05 亚克蒂斯Ip有限公司 包含pcl的微粒及其用途
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US20090081173A1 (en) * 2007-08-10 2009-03-26 The Board Of Regents Of The University Of Texas System Methods and compositions involving bacteriophage isolates
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8709395B2 (en) 2007-10-29 2014-04-29 Ayman Boutros Method for repairing or replacing damaged tissue
US8475815B2 (en) 2007-10-29 2013-07-02 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US7910134B2 (en) * 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8431141B2 (en) * 2007-10-29 2013-04-30 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
HUE042931T2 (hu) 2007-11-16 2019-07-29 Aclaris Therapeutics Inc Kompozíciók és eljárások purpura kezelésére
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CA2709581C (en) * 2007-12-17 2013-06-11 Anna Love Soft tissue filler
US20090198331A1 (en) * 2008-02-01 2009-08-06 Kesten Randy J Implantable prosthesis with open cell flow regulation
US20090198329A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Breast implant with internal flow dampening
US8678008B2 (en) * 2008-07-30 2014-03-25 Ethicon, Inc Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8556797B2 (en) * 2008-07-31 2013-10-15 Ethicon, Inc. Magnetic implants for treating obstructive sleep apnea and methods therefor
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US8413661B2 (en) 2008-08-14 2013-04-09 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
US20100080791A1 (en) * 2008-09-26 2010-04-01 Rousseau Robert A Composition and Method For Treating Tissue Defects
US8561616B2 (en) 2008-10-24 2013-10-22 Ethicon, Inc. Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US8561617B2 (en) 2008-10-30 2013-10-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8783258B2 (en) 2008-12-01 2014-07-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8800567B2 (en) 2008-12-01 2014-08-12 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8371308B2 (en) 2009-02-17 2013-02-12 Ethicon, Inc. Magnetic implants and methods for treating an oropharyngeal condition
US8307831B2 (en) 2009-03-16 2012-11-13 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US10105197B1 (en) 2009-03-26 2018-10-23 Fernando Colon Method of treatment for periodontal pockets
US9200112B2 (en) 2009-08-10 2015-12-01 Ethicon, Inc. Semi-crystalline, fast absorbing polymer formulation
US9326886B2 (en) 2009-10-29 2016-05-03 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US9877862B2 (en) * 2009-10-29 2018-01-30 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9044524B2 (en) * 2009-10-30 2015-06-02 Ethicon, Inc. Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
US9974683B2 (en) * 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US8632488B2 (en) 2009-12-15 2014-01-21 Ethicon, Inc. Fluid filled implants for treating medical conditions
US8980248B2 (en) 2009-12-18 2015-03-17 The Governing Council Of The University Of Toronto Injectable polymer composition for use as a cell delivery vehicle
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
CA2792729C (en) 2010-03-12 2016-06-28 Allergan Industrie, Sas Fluid compositions for improving skin conditions
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US8815228B2 (en) 2010-04-30 2014-08-26 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
KR101003331B1 (ko) 2010-05-11 2010-12-23 조강선 피부 충전제 조성물
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
EP3536307B1 (de) 2011-06-03 2021-10-20 ALLERGAN Industrie, SAS Dermale füllstoffzusammensetzungen mit antioxidantien
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US8905033B2 (en) 2011-09-28 2014-12-09 Ethicon, Inc. Modular tissue securement systems
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
WO2017114865A1 (en) 2015-12-29 2017-07-06 Galderma S.A. Hydrolysis of ester bonds in amide crosslinked glycosaminoglycans
CN105664261B (zh) * 2016-02-18 2018-09-21 江苏西宏生物医药有限公司 一种注射植入剂的制备方法
CN105727370B (zh) * 2016-02-18 2018-11-06 江苏西宏生物医药有限公司 一种注射植入剂
KR101852127B1 (ko) 2016-04-11 2018-04-25 주식회사 지씨에스 폴리엘락틱산 필러와 히알루론산 필러 결합체의 제조방법
RU2641053C1 (ru) * 2016-09-21 2018-01-15 Наталья Павловна Михайлова Твёрдофазный способ получения биоактивного композита для наращивания ткани на основе гиалуроновой кислоты и микрочастиц полилактида или его сополимеров и способ получения имплантата на основе этого композита
US10821200B2 (en) * 2016-12-05 2020-11-03 Hyalo Technologies, LLC Method of sterilization of microparticles
CN108619563A (zh) * 2017-03-18 2018-10-09 浙江臻我生物技术有限公司 一种聚乳酸组合物及其制备方法
CN108619564A (zh) * 2017-03-18 2018-10-09 浙江臻我生物技术有限公司 一种用于皮肤填充的组合物及其制备方法
EP3409301B1 (de) 2017-05-30 2021-02-17 Aqpha Ip B.V. Resorbierende bioabbaubare medizinische und kosmetische zusammensetzung
KR20210121020A (ko) * 2018-12-21 2021-10-07 갈더마 홀딩 소시에떼 아노님 고체 입자를 봉입한 히드로겔 조성물
WO2020184744A1 (ko) * 2019-03-08 2020-09-17 주식회사 지씨에스 복합체의 제조 방법
US20200376128A1 (en) 2019-06-01 2020-12-03 Lupin Holdings B.V. Monodisperse resorbable polyester polymer compositions, systems, and methods
CN110339397B (zh) * 2019-07-11 2021-12-21 山东省药学科学院 一种不含助悬剂的可注射皮肤填充剂及其制备方法和用途
CN110327497A (zh) * 2019-07-31 2019-10-15 易浦润(上海)生物技术有限公司 一种含微球的注射用凝胶及其制备方法
TW202128120A (zh) 2019-10-28 2021-08-01 瑞士商葛德瑪控股公司 即用型美容組成物
JP2023504528A (ja) 2019-12-02 2023-02-03 ガルデルマ ホールディング エスエー 高分子量美容組成物
CN113058074B (zh) * 2020-01-02 2022-04-29 华利源(上海)生物医药科技有限公司 温敏填充剂组合物
CN113117143B (zh) * 2020-01-14 2023-11-28 渼颜空间(河北)生物科技有限公司 透明质酸用于制备可生物降解的聚合物微粒制剂的应用
CN111150883A (zh) * 2020-01-14 2020-05-15 北京四环制药有限公司 可生物降解的注射填充物及其制备方法和其应用
CN114099771A (zh) * 2020-08-27 2022-03-01 杭州协合医疗用品有限公司 一种含混合聚合物微球的梯度注射剂
KR102266384B1 (ko) * 2021-01-25 2021-06-21 주식회사 울트라브이 필러용 생분해성 고분자 미세입자, 이를 포함한 필러용 동결건조체, 그 제조방법 및 상기 동결건조체를 포함하는 필러용 주사제
CN113877000B (zh) * 2021-10-13 2023-01-24 科笛生物医药(无锡)有限公司 注射用微球组合物及其应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185152A (en) * 1939-12-26 Diazo derivatives of gtjanidyl
US2756867A (en) * 1950-11-21 1956-07-31 Joy Mfg Co Conveyor chain with replaceable flights
US2758987A (en) 1952-06-05 1956-08-14 Du Pont Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CH530951A (de) * 1970-08-04 1972-11-30 Ciba Geigy Ag Verfahren zur Herstellung von 2,3-disubstituierten 1,3-Butadienen
CH611150A5 (de) * 1975-04-18 1979-05-31 Sulzer Ag
US4166800A (en) 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
US4919929A (en) 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
CA1196864A (en) 1983-06-10 1985-11-19 Mattheus F.A. Goosen Controlled release of injectable and implantable insulin compositions
US5061281A (en) 1985-12-17 1991-10-29 Allied-Signal Inc. Bioresorbable polymers and implantation devices thereof
EP0226061B1 (de) 1985-12-17 1994-02-16 United States Surgical Corporation Bioresorbierbare Polymere von hohem Molekulargewicht und Implantate davon
US4780320A (en) 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法
FR2618674B1 (fr) 1987-07-30 1990-06-15 Ire Celltarg Sa Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US4897287A (en) 1988-10-06 1990-01-30 The Boc Group, Inc. Metallization process for an integrated circuit
DE3841401A1 (de) 1988-12-08 1990-06-13 Martin Lemperle Alloplastisches implantat
US5258028A (en) * 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5185152A (en) 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
US5059123A (en) 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5288496A (en) 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
ATE142460T1 (de) * 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
US5356629A (en) * 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
EP0544097A1 (de) 1991-10-23 1993-06-02 Boehringer Ingelheim Kg Halbfeste Mischungen aus Oligomeren und/oder Polymeren auf der Basis von Milchsäure, Verfahren zur deren Herstellung und deren Verwendung als resorbierbare Implantate
DE4235312A1 (de) 1991-10-23 1993-04-29 Boehringer Ingelheim Kg Halbfeste mischungen aus oligomeren und/oder polymeren auf der basis von milchsaeure, verfahren zu deren herstellung und deren verwendung als resorbierbare implantate
FR2686250A1 (fr) * 1992-01-16 1993-07-23 Coletica Compositions injectables contenant en suspension des microcapsules a base de collagene, leur utilisation biomedicale et des compositions pharmaceutiques.
WO1993015722A1 (en) 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
ZA93506B (en) * 1992-02-11 1994-05-11 Bristol Myers Squibb Co Soft tissue augmentation material
US5204382A (en) 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
GB9206509D0 (en) * 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
SE509991C2 (sv) 1992-07-20 1999-03-29 Bengt Hjalmar Aagerup Med Firm Biologiskt nedbrytbar vävnadsförstärkning
NZ250214A (en) * 1992-12-23 1995-10-26 Ndm Acquisition Corp Deep wound dressing and syringe therefor
EP0784487A1 (de) 1993-03-19 1997-07-23 Medinvent Ein präparat und ein verfahren zur gewebevermehrung
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
JPH07125508A (ja) 1993-09-09 1995-05-16 Bridgestone Corp 空気入りタイヤ
GB2281861B (en) * 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
JPH07265421A (ja) 1994-03-28 1995-10-17 Shibuya Kogyo Co Ltd ダブルチャンバーシリンジの製造方法
US5478837A (en) 1994-06-07 1995-12-26 University Of Southern California Use of quinacrine in preventing adhesion formation
US5451406A (en) * 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
AU706434B2 (en) * 1994-10-18 1999-06-17 Ethicon Inc. Injectable liquid copolymers for soft tissue repair and augmentation
US5599852A (en) * 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US6287341B1 (en) * 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US5977204A (en) * 1997-04-11 1999-11-02 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
WO1999011196A1 (en) * 1997-09-04 1999-03-11 Point Biomedical Corporation Injectable tissue reconstruction material
WO1999058082A2 (en) 1998-05-14 1999-11-18 The Cleveland Clinic Foundation Processing of implantable animal tissues for dry storage
FR2778847A1 (fr) * 1998-05-20 1999-11-26 Jean Pierre Perraud Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur
KR20030029621A (ko) * 2000-07-14 2003-04-14 카이폰 인코포레이티드 척추체의 치료 시스템 및 방법

Also Published As

Publication number Publication date
PT969883E (pt) 2004-04-30
KR20000068167A (ko) 2000-11-25
CA2263361C (fr) 2006-10-24
US8414657B2 (en) 2013-04-09
IL128210A0 (en) 1999-11-30
RU2214283C2 (ru) 2003-10-20
FR2764514B1 (fr) 1999-09-03
AU8218298A (en) 1998-12-30
US20100221684A1 (en) 2010-09-02
IL128210A (en) 2004-02-19
WO1998056431A1 (fr) 1998-12-17
EP0969883A1 (de) 2000-01-12
PL331703A1 (en) 1999-08-02
ES2210776T3 (es) 2004-07-01
DK0969883T3 (da) 2004-03-01
RO118261B1 (ro) 2003-04-30
BR9804962A (pt) 1999-09-08
HUP0001465A3 (en) 2001-11-28
HUP0001465A2 (hu) 2000-10-28
DE69819694T2 (de) 2004-09-30
TR199900297T1 (xx) 1999-09-21
JP2000516839A (ja) 2000-12-19
FR2764514A1 (fr) 1998-12-18
US6716251B1 (en) 2004-04-06
CA2263361A1 (fr) 1998-12-17
US20120231046A1 (en) 2012-09-13
KR100543560B1 (ko) 2006-01-20
HK1025268A1 (en) 2000-11-10
AU744366B2 (en) 2002-02-21
ATE253947T1 (de) 2003-11-15
EP0969883B1 (de) 2003-11-12
HU228462B1 (en) 2013-03-28
US7731758B2 (en) 2010-06-08
US20040191323A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
DE69819694D1 (de) Subkutan oder intradermal injizierbares implantat in der plastischen oder wiederherstellenden chirurgie
JP5563984B2 (ja) 注射用アロプラスト皮膚充填材およびその使用方法
FR2299009A1 (fr) Implant dentaire a ligament alveolo-dentaire artificiel
DE69332871D1 (de) Verfahren zur Herstellung von Keramikpartikeln
IT1107152B (it) Dente artificiale con radice implantabile
BRPI0708872A2 (pt) mÉtodo para aumentar uma regiço de tecido mole, kit, mÉtodo para fabricar uma composiÇço de medicamento, e, composiÇço para o aumento de tecido injetÁvel
AR004492A1 (es) Cabello artificial para implante y procedimiento para producir el mismo
KR101987783B1 (ko) 생분해성 고분자 미립자 및 그 제조방법, 및 이를 포함하는 생분해성 고분자 필러
DE602004017125D1 (de) Injizierbare implantate auf keramikbasis zur füllung von weichgewebe
ATE217514T1 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
Harini et al. Periodontal soft tissue expanders-a review
ATE382378T1 (de) Implantatmaterial
IT1313580B1 (it) Dispositivo per impianto dentale.
Assessment COS DERM
BR0002334A (pt) Implante dentário, processo de implantação dentária e processo de obtenção de um implante dentário estéril liofilizado
UA37724A (uk) Зубний імплантат

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS (IRELAND) LTD., DUBLIN, IE

8365 Fully valid after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMACEUTICALS HOLDINGS INC., GREENVI, US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMACEUTICALS INC., BRIDGEWATER, N.J, US

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC